NYSE:LH - LabCorp Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$175.40 -0.17 (-0.10 %)
(As of 05/25/2018 07:12 AM ET)
Previous Close$175.57
Today's Range$174.20 - $176.04
52-Week Range$137.82 - $181.71
Volume354,985 shs
Average Volume680,267 shs
Market Capitalization$17.89 billion
P/E Ratio18.27
Dividend YieldN/A
Beta0.93

About LabCorp (NYSE:LH)

LabCorp logoLaboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates through two segments, LabCorp Diagnostics and Covance Drug Development. It offers a range of clinical laboratory tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C, prostate-specific antigen, tests for sexually-transmitted diseases, hepatitis C tests, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests that are used by hospitals, physicians and other healthcare providers and commercial clients to assist in the diagnosis, monitoring and treatment of diseases and medical conditions through the examination of substances in blood, tissues, and other specimens. The company also provides specialty testing services in the areas of women's health, allergy, diagnostic genetics, cardiovascular disease, infectious disease, endocrinology, oncology, coagulation, pharmacogenetics, toxicology, medical drug monitoring, and pain management; and esoteric testing, cancer diagnostics, and other complex procedures. In addition, it provides drug development solutions and laboratory testing services; and testing services through a sales force to the managed care organizations, biopharmaceutical companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, food and nutritional companies, and independent clinical laboratories. The company has collaboration with university, hospital and academic institutions, such as Boston University, Columbia University, Duke University, Johns Hopkins University, The Mount Sinai Hospital, the University of Tennessee, and Yale University to license and commercialize new diagnostic tests. Laboratory Corporation of America Holdings was founded in 1971 and is headquartered in Burlington, North Carolina.

Receive LH News and Ratings via Email

Sign-up to receive the latest news and ratings for LH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical laboratories
Sub-IndustryHealth Care Services
SectorMedical
SymbolNYSE:LH
CUSIP50540R40
Phone336-229-1127

Debt

Debt-to-Equity Ratio0.91
Current Ratio1.38
Quick Ratio1.27

Price-To-Earnings

Trailing P/E Ratio18.27
Forward P/E Ratio15.17
P/E Growth1.54

Sales & Book Value

Annual Sales$10.44 billion
Price / Sales1.71
Cash Flow$15.0171 per share
Price / Cash11.68
Book Value$68.54 per share
Price / Book2.56

Profitability

EPS (Most Recent Fiscal Year)$9.60
Net Income$1.27 billion
Net Margins11.52%
Return on Equity16.33%
Return on Assets6.49%

Miscellaneous

Employees60,000
Outstanding Shares101,900,000

LabCorp (NYSE:LH) Frequently Asked Questions

What is LabCorp's stock symbol?

LabCorp trades on the New York Stock Exchange (NYSE) under the ticker symbol "LH."

How were LabCorp's earnings last quarter?

LabCorp (NYSE:LH) released its quarterly earnings results on Wednesday, April, 25th. The medical research company reported $2.78 earnings per share for the quarter, beating analysts' consensus estimates of $2.63 by $0.15. The medical research company had revenue of $2.85 billion for the quarter, compared to analysts' expectations of $2.77 billion. LabCorp had a net margin of 11.52% and a return on equity of 16.33%. The company's revenue was up 18.0% compared to the same quarter last year. During the same period last year, the business earned $2.22 EPS. View LabCorp's Earnings History.

When is LabCorp's next earnings date?

LabCorp is scheduled to release their next quarterly earnings announcement on Wednesday, July, 25th 2018. View Earnings Estimates for LabCorp.

What guidance has LabCorp issued on next quarter's earnings?

LabCorp issued an update on its FY18 earnings guidance on Wednesday, April, 25th. The company provided earnings per share (EPS) guidance of $11.30-11.70 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $11.54.

What price target have analysts set for LH?

16 analysts have issued 1 year target prices for LabCorp's shares. Their forecasts range from $172.00 to $210.00. On average, they expect LabCorp's stock price to reach $190.4667 in the next twelve months. View Analyst Ratings for LabCorp.

Who are some of LabCorp's key competitors?

Who are LabCorp's key executives?

LabCorp's management team includes the folowing people:
  • Mr. David P. King, Chairman, CEO & Pres (Age 62)
  • Mr. Glenn A. Eisenberg, CFO & Exec. VP (Age 57)
  • Mr. Lance V. Berberian, Chief Information Officer & Sr. VP (Age 55)
  • Mr. F. Samuel Eberts III, Chief Legal Officer, Chief Compliance Officer, Sr. VP & Sec. (Age 58)
  • Ms. Lisa J. Uthgenannt, Chief HR Officer & Sr. VP (Age 57)

Has LabCorp been receiving favorable news coverage?

News headlines about LH stock have been trending somewhat positive this week, Accern reports. The research group identifies negative and positive press coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. LabCorp earned a news sentiment score of 0.18 on Accern's scale. They also gave media headlines about the medical research company an impact score of 45.89 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the near future.

Who are LabCorp's major shareholders?

LabCorp's stock is owned by many different of retail and institutional investors. Top institutional investors include BlackRock Inc. (7.83%), Boston Partners (5.57%), Iridian Asset Management LLC CT (1.66%), Dimensional Fund Advisors LP (1.40%), JPMorgan Chase & Co. (1.38%) and Northern Trust Corp (1.35%). Company insiders that own LabCorp stock include Adam H Schechter, David P King, Dwight Gary Gilliland, F Samuel Eberts III, Glenn A Eisenberg, Jean-Luc Belingard, Lance Berberian, Lisa J Uthgenannt, R Sanders Williams and Robert E Mittelstaedt Jr. View Institutional Ownership Trends for LabCorp.

Which major investors are selling LabCorp stock?

LH stock was sold by a variety of institutional investors in the last quarter, including Check Capital Management Inc. CA, State of New Jersey Common Pension Fund D, Millennium Management LLC, Global Thematic Partners LLC, Thompson Siegel & Walmsley LLC, Sentry Investments Corp., Swiss National Bank and Tamarack Advisers LP. Company insiders that have sold LabCorp company stock in the last year include Adam H Schechter, David P King, Dwight Gary Gilliland, F Samuel Eberts III, Glenn A Eisenberg, Lisa J Uthgenannt and R Sanders Williams. View Insider Buying and Selling for LabCorp.

Which major investors are buying LabCorp stock?

LH stock was bought by a variety of institutional investors in the last quarter, including Amundi Pioneer Asset Management Inc., Boston Partners, Rothschild Asset Management Inc., Royal Bank of Canada, Teacher Retirement System of Texas, Stevens Capital Management LP, Iridian Asset Management LLC CT and University of Notre Dame DU Lac. View Insider Buying and Selling for LabCorp.

How do I buy shares of LabCorp?

Shares of LH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is LabCorp's stock price today?

One share of LH stock can currently be purchased for approximately $175.40.

How big of a company is LabCorp?

LabCorp has a market capitalization of $17.89 billion and generates $10.44 billion in revenue each year. The medical research company earns $1.27 billion in net income (profit) each year or $9.60 on an earnings per share basis. LabCorp employs 60,000 workers across the globe.

How can I contact LabCorp?

LabCorp's mailing address is 358 South Main Street, BURLINGTON NC, 27215. The medical research company can be reached via phone at 336-229-1127 or via email at [email protected]


MarketBeat Community Rating for LabCorp (LH)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  357 (Vote Outperform)
Underperform Votes:  397 (Vote Underperform)
Total Votes:  754
MarketBeat's community ratings are surveys of what our community members think about LabCorp and other stocks. Vote "Outperform" if you believe LH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LH will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

LabCorp (NYSE:LH) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
16 Wall Street analysts have issued ratings and price targets for LabCorp in the last 12 months. Their average twelve-month price target is $190.4667, suggesting that the stock has a possible upside of 8.59%. The high price target for LH is $210.00 and the low price target for LH is $172.00. There are currently 4 hold ratings, 11 buy ratings and 1 strong buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.812.752.672.58
Ratings Breakdown: 0 Sell Rating(s)
4 Hold Rating(s)
11 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
10 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
6 Hold Rating(s)
8 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $190.4667$189.1333$180.0714$168.6364
Price Target Upside: 8.59% upside14.14% upside8.83% upside11.61% upside

LabCorp (NYSE:LH) Consensus Price Target History

Price Target History for LabCorp (NYSE:LH)

LabCorp (NYSE:LH) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/25/2018MizuhoReiterated RatingHoldLowView Rating Details
5/1/2018Robert W. BairdUpgradeNeutral ➝ Outperform$183.00 ➝ $203.00LowView Rating Details
3/23/2018ArgusInitiated CoverageBuy$202.00HighView Rating Details
3/8/2018Credit Suisse GroupReiterated RatingOutperform ➝ Outperform$192.00 ➝ $195.00LowView Rating Details
3/6/2018Jefferies GroupReiterated RatingHold$176.00MediumView Rating Details
2/28/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$182.00 ➝ $192.00MediumView Rating Details
2/28/2018Canaccord GenuityBoost Price TargetBuy ➝ Buy$190.00 ➝ $195.00MediumView Rating Details
2/26/2018BarclaysBoost Price TargetOverweight ➝ Overweight$195.00 ➝ $210.00MediumView Rating Details
2/9/2018CitigroupBoost Price TargetNeutral ➝ Neutral$161.00 ➝ $184.00MediumView Rating Details
2/7/2018Craig HallumReiterated RatingBuy$180.00 ➝ $204.00LowView Rating Details
1/29/2018Goldman Sachs GroupInitiated CoverageNeutral ➝ Buy$128.00 ➝ $205.00LowView Rating Details
1/4/2018Evercore ISIInitiated CoverageOutperform ➝ Outperform$176.00HighView Rating Details
10/26/2017Deutsche BankBoost Price TargetBuy$170.00 ➝ $172.00N/AView Rating Details
10/12/2017SunTrust BanksReiterated RatingBuy$190.00N/AView Rating Details
10/12/2017Wells Fargo & CoInitiated CoverageMarket Perform ➝ Outperform$175.00N/AView Rating Details
9/26/2017KeyCorpReiterated RatingHoldLowView Rating Details
10/25/2016GabelliInitiated CoverageBuy$180.00N/AView Rating Details
7/28/2016UBSBoost Price TargetNeutral$125.00 ➝ $137.50N/AView Rating Details
(Data available from 5/25/2016 forward)

Earnings

LabCorp (NYSE:LH) Earnings History and Estimates Chart

Earnings by Quarter for LabCorp (NYSE:LH)

LabCorp (NYSE:LH) Earnings Estimates

2018 EPS Consensus Estimate: $11.19
2019 EPS Consensus Estimate: $12.33
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20185$2.34$2.75$2.52
Q2 20186$2.63$2.95$2.87
Q3 20186$2.66$2.97$2.87
Q4 20186$2.68$3.09$2.93
Q1 20193$2.87$2.95$2.90
Q2 20193$3.15$3.19$3.17
Q3 20193$3.01$3.22$3.13
Q4 20193$3.08$3.20$3.12

LabCorp (NYSE LH) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/24/2018$2.94N/AView Earnings Details
4/25/2018Q1 2018$2.63$2.78$2.7742 billion$2.8480 billionViewN/AView Earnings Details
2/6/2018Q4 2017$2.38$2.45$2.6985 billion$2.7015 billionViewListenView Earnings Details
10/25/2017Q3 2017$2.38$2.46$2.5545 billion$2.5970 billionViewN/AView Earnings Details
7/26/2017Q2 2017$2.40$2.47$2.4672 billion$2.4984 billionViewN/AView Earnings Details
4/25/2017Q1 2017$2.19$2.22$2.4090 billion$2.4081 billionViewN/AView Earnings Details
2/16/2017Q416$2.13$2.15$2.35 billion$2.39 billionViewListenView Earnings Details
10/26/2016Q316$2.29$2.25$2.38 billion$2.40 billionViewListenView Earnings Details
7/27/2016Q216$2.30$2.31$2.33 billion$2.40 billionViewListenView Earnings Details
4/25/2016Q116$1.96$2.02$2.19 billion$2.30 billionViewListenView Earnings Details
2/18/2016Q415$1.99$1.98$2.22 billion$2.24 billionViewListenView Earnings Details
10/26/2015Q315$2.07$2.07$2.25 billion$2.30 billionViewListenView Earnings Details
7/28/2015Q215$2.03$2.09$2.22 billion$2.20 billionViewListenView Earnings Details
4/27/2015Q115$1.63$1.73$1.79 billion$1.80 billionViewListenView Earnings Details
2/20/2015Q4$1.63$1.65$1.4941 billion$1.5127 billionViewListenView Earnings Details
10/28/2014Q3$1.75$1.80$1.56 billion$1.55 billionViewListenView Earnings Details
7/18/2014Q214$1.77$1.84$1.50 billion$1.52 billionViewN/AView Earnings Details
4/28/2014Q114$1.58$1.51$1.45 billion$1.43 billionViewListenView Earnings Details
2/7/2014Q413$1.66$1.61$1.46 billion$1.44 billionViewListenView Earnings Details
10/18/2013Q313$1.80$1.80$1.45 billion$1.46 billionViewListenView Earnings Details
7/19/2013Q2 2013$1.80$1.80$1.46 billion$1.47 billionViewListenView Earnings Details
4/19/2013Q1 2013$1.77$1.74$1.4489 billion$1.4410 billionViewListenView Earnings Details
2/8/2013Q4 2012$1.62$1.54$1.39 billion$1.41 billionViewListenView Earnings Details
10/18/2012$1.74$1.76ViewN/AView Earnings Details
7/19/2012$1.76$1.77ViewN/AView Earnings Details
4/19/2012$1.67$1.74ViewN/AView Earnings Details
2/10/2012$1.41$1.46ViewN/AView Earnings Details
10/20/2011$1.50$1.61ViewN/AView Earnings Details
7/21/2011$1.53$1.64ViewN/AView Earnings Details
4/21/2011$1.46$1.52ViewN/AView Earnings Details
2/10/2011$1.31$1.34ViewN/AView Earnings Details
10/21/2010Q3 2010$1.40$1.47ViewN/AView Earnings Details
7/22/2010Q2 2010$1.42$1.46ViewN/AView Earnings Details
4/21/2010Q1 2010$1.31$1.30ViewN/AView Earnings Details
2/11/2010Q4 2009$1.15$1.16ViewN/AView Earnings Details
10/22/2009Q3 2009$1.15$1.22ViewN/AView Earnings Details
7/23/2009Q2 2009$1.27$1.30ViewN/AView Earnings Details
4/23/2009Q1 2009$1.17$1.22ViewN/AView Earnings Details
2/12/2009Q4 2008$1.09$1.10ViewN/AView Earnings Details
10/23/2008Q3 2008$1.12$1.13ViewN/AView Earnings Details
7/24/2008Q2 2008$1.24$1.24ViewN/AView Earnings Details
4/24/2008Q1 2008$1.14$1.14ViewN/AView Earnings Details
2/7/2008Q4 2007$1.00$1.04ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

LabCorp (NYSE:LH) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

LabCorp (NYSE LH) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.73%
Institutional Ownership Percentage: 92.40%
Insider Trading History for LabCorp (NYSE:LH)
Institutional Ownership by Quarter for LabCorp (NYSE:LH)

LabCorp (NYSE LH) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/23/2018David P KingCEOSell49,967$166.12$8,300,518.04271,636View SEC Filing  
3/23/2018David P KingCEOSell49,967$164.75$8,232,063.25231,202View SEC Filing  
2/12/2018Glenn A EisenbergCFOSell8,400$167.36$1,405,824.0015,931View SEC Filing  
2/8/2018Adam H SchechterDirectorSell1,263$169.29$213,813.277,297View SEC Filing  
10/30/2017Dwight Gary GillilandDirectorSell971$153.52$149,067.923,501View SEC Filing  
9/6/2017David P KingCEOSell44,687$156.86$7,009,602.82258,753View SEC Filing  
9/5/2017David P. KingCEOSell132,713$157.06$20,843,903.78View SEC Filing  
8/25/2017F Samuel Eberts IIIInsiderSell31,500$155.22$4,889,430.0031,894View SEC Filing  
8/11/2017R Sanders WilliamsDirectorSell3,100$156.88$486,328.0010,073View SEC Filing  
8/1/2017Glenn A EisenbergCFOSell5,968$159.46$951,657.2818,122View SEC Filing  
8/1/2017Lisa J. UthgenanntInsiderSell5,000$160.00$800,000.00View SEC Filing  
5/22/2017Lance BerberianSVPSell3,613$139.84$505,241.925,789View SEC Filing  
5/9/2017Jean-Luc BelingardDirectorSell992$142.19$141,052.4832,935View SEC Filing  
3/9/2017Glenn A EisenbergCFOSell2,300$142.47$327,681.0012,556View SEC Filing  
2/24/2017Robert E Mittelstaedt JrDirectorSell5,300$142.69$756,257.0018,208View SEC Filing  
8/9/2016Lisa J UthgenanntInsiderSell1,177$140.00$164,780.003,660View SEC Filing  
8/4/2016Glenn A EisenbergCFOSell8,000$140.10$1,120,800.008,668View SEC Filing  
8/4/2016Robert E Mittelstaedt JrDirectorSell992$140.15$139,028.8012,340View SEC Filing  
6/13/2016David P KingCEOSell196,400$128.00$25,139,200.00271,210View SEC Filing  
4/27/2016Edward T DodsonInsiderSell9,392$126.42$1,187,336.642,717View SEC Filing  
3/31/2016F Samuel Eberts IIIInsiderSell4,219$116.85$492,990.1524,751View SEC Filing  
3/31/2016James T Jr. BoyleCEOSell18,132$116.81$2,117,998.9258,191View SEC Filing  
3/14/2016F Samuel Eberts IIIInsiderSell309$115.32$35,633.8818,529View SEC Filing  
3/14/2016James T Jr. BoyleCEOSell1,543$115.32$177,938.7626,410View SEC Filing  
2/25/2016Jean-Luc BelingardDirectorSell1,296$109.74$142,223.0430,722View SEC Filing  
2/16/2016F Samuel Eberts IIIInsiderSell370$103.02$38,117.4018,066View SEC Filing  
2/16/2016James T. Jr. BoyleCEOSell4,055$103.02$417,746.1023,454View SEC Filing  
2/12/2016F Samuel Eberts IIIinsiderSell405$101.67$41,176.3518,436View SEC Filing  
2/12/2016James T. Jr. BoyleCEOSell2,712$101.67$275,729.0427,509View SEC Filing  
1/8/2016F Samuel Eberts IIIInsiderSell1,215$119.05$144,645.7518,066View SEC Filing  
12/8/2015F Samuel Eberts IIIInsiderSell1,010$123.31$124,543.1019,281View SEC Filing  
11/2/2015R Sanders WilliamsDirectorSell1,850$124.30$229,955.004,176View SEC Filing  
7/1/2015David P KingCEOSell50,000$121.78$6,089,000.00View SEC Filing  
4/29/2015Jean-Luc BelingardDirectorSell1,542$123.10$189,820.20View SEC Filing  
4/23/2015James T Jr. BoyleCEOSell1,394$126.56$176,424.64View SEC Filing  
3/31/2015Mark E BrecherCMOSell20,625$126.98$2,618,962.50View SEC Filing  
3/30/2015Mark E BrecherCMOSell20,278$126.98$2,574,900.44View SEC Filing  
3/3/2015James T Jr. BoyleCOOSell1,237$123.70$153,016.90View SEC Filing  
2/13/2015James T Jr. BoyleCOOSell6,597$116.68$769,737.96View SEC Filing  
9/22/2014David P KingCEOSell65,234$104.71$6,830,652.14View SEC Filing  
9/5/2014R Sanders WilliamsDirectorSell2,000$107.95$215,900.00View SEC Filing  
8/22/2014David P KingCEOSell65,233$106.10$6,921,221.30View SEC Filing  
7/22/2014David P KingCEOSell65,233$105.55$6,885,343.15View SEC Filing  
6/9/2014James T Jr. BoyleCOOSell38,600$103.00$3,975,800.00View SEC Filing  
5/7/2014M Keith WeikelDirectorSell1,984$98.28$194,987.5213,958View SEC Filing  
3/28/2014James Jr. BoyleCOOSell2,521$98.36$247,965.5625,821View SEC Filing  
3/7/2014William HayesCFOSell23,848$94.40$2,251,251.2019,400View SEC Filing  
2/13/2014James Jr. BoyleCOOSell4,123$90.29$372,265.6728,188View SEC Filing  
2/11/2014James Jr. BoyleCOOSell1,204$91.15$109,744.6028,188View SEC Filing  
1/27/2014David KingCEOSell24,200$90.15$2,181,630.0063,699View SEC Filing  
12/24/2013David KingCEOSell25,000$90.79$2,269,750.0063,628View SEC Filing  
10/24/2013David P KingCEOSell25,000$100.91$2,522,750.00View SEC Filing  
10/17/2013James T Jr. BoyleCOOSell24,400$102.00$2,488,800.00View SEC Filing  
9/25/2013David KingCEOSell25,000$99.06$2,476,500.0063,628View SEC Filing  
8/26/2013David KingCEOSell25,000$96.60$2,415,000.0063,628View SEC Filing  
8/21/2013Robert Mittelstaedt, Jr.DirectorSell7,429$96.86$719,572.947,015View SEC Filing  
7/24/2013David P KingCEOSell25,000$97.72$2,443,000.00View SEC Filing  
6/24/2013David P KingCEOSell25,000$98.66$2,466,500.00View SEC Filing  
6/7/2013James T Jr. BoyleCOOSell63,100$99.63$6,286,653.00View SEC Filing  
5/28/2013Mark E BrecherInsiderSell16,900$100.92$1,705,548.00View SEC Filing  
5/21/2013William B HayesCFOSell127,200$100.00$12,720,000.00View SEC Filing  
5/17/2013F Samuel Eberts IIIInsiderSell10,000$98.47$984,700.00View SEC Filing  
5/10/2013James T Jr. BoyleCOOSell68,908$93.82$6,464,948.56View SEC Filing  
5/8/2013Jean-Luc BelingardDirectorSell2,536$92.88$235,543.68View SEC Filing  
4/11/2013William B HayesCFOSell22,234$95.00$2,112,230.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

LabCorp (NYSE LH) News Headlines

Source:
DateHeadline
LabCorp (LH) Receives Consensus Recommendation of "Buy" from AnalystsLabCorp (LH) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - May 25 at 3:30 AM
UnitedHealthcare Establishes Long-term Strategic Partnership with LabCorpUnitedHealthcare Establishes Long-term Strategic Partnership with LabCorp
finance.yahoo.com - May 24 at 4:41 PM
Critical Analysis: CareDx (CDNA) and LabCorp (LH)Critical Analysis: CareDx (CDNA) and LabCorp (LH)
www.americanbankingnews.com - May 20 at 7:22 PM
$2.85 Billion in Sales Expected for LabCorp (LH) This Quarter$2.85 Billion in Sales Expected for LabCorp (LH) This Quarter
www.americanbankingnews.com - May 17 at 2:19 AM
Triad can count April as victory for jobs deals vs. layoffsTriad can count April as victory for jobs deals vs. layoffs
finance.yahoo.com - May 16 at 4:40 PM
State data shows job announcements outweigh layoff notices in the TriangleState data shows job announcements outweigh layoff notices in the Triangle
finance.yahoo.com - May 16 at 9:29 AM
 Analysts Expect LabCorp (LH) Will Post Earnings of $2.92 Per Share Analysts Expect LabCorp (LH) Will Post Earnings of $2.92 Per Share
www.americanbankingnews.com - May 15 at 7:14 PM
Critical Review: LabCorp (LH) versus Elekta (EKTAY)Critical Review: LabCorp (LH) versus Elekta (EKTAY)
www.americanbankingnews.com - May 15 at 1:39 PM
Head-To-Head Review: Veracyte (VCYT) versus Laboratory Corp. of America (LH)Head-To-Head Review: Veracyte (VCYT) versus Laboratory Corp. of America (LH)
www.americanbankingnews.com - May 6 at 8:00 PM
LabCorp to Webcast Its Annual Meeting of ShareholdersLabCorp to Webcast Its Annual Meeting of Shareholders
finance.yahoo.com - May 3 at 9:09 AM
UPDATE: Baird Upgrades Laboratory Corporation of America (LH) to OutperformUPDATE: Baird Upgrades Laboratory Corporation of America (LH) to Outperform
www.streetinsider.com - May 2 at 9:13 AM
Laboratory Corp. of America Holdings Forecasted to Earn Q2 2018 Earnings of $2.89 Per Share (LH)Laboratory Corp. of America Holdings Forecasted to Earn Q2 2018 Earnings of $2.89 Per Share (LH)
www.americanbankingnews.com - May 2 at 9:02 AM
Laboratory Corporation of America Holdings -- Moodys: LabCorps Divestiture of Food Solutions Business is Credit PositiveLaboratory Corporation of America Holdings -- Moody's: LabCorp's Divestiture of Food Solutions Business is Credit Positive
finance.yahoo.com - May 1 at 4:32 PM
LabCorp takes on the opioid crisis with its latest partnershipLabCorp takes on the opioid crisis with its latest partnership
finance.yahoo.com - May 1 at 4:32 PM
LabCorp Announces Collaboration with The Recovery Platform to Assist Physicians Treating Patients with Opioid DependencyLabCorp Announces Collaboration with The Recovery Platform to Assist Physicians Treating Patients with Opioid Dependency
finance.yahoo.com - May 1 at 9:16 AM
Merger Monday Makes A ReturnMerger Monday Makes A Return
finance.yahoo.com - May 1 at 9:16 AM
Laboratory Corp. of America (LH) Lifted to "Buy" at Robert W. BairdLaboratory Corp. of America (LH) Lifted to "Buy" at Robert W. Baird
www.americanbankingnews.com - May 1 at 7:17 AM
Laboratory Corp. of America Holdings to Post Q4 2018 Earnings of $2.89 Per Share, William Blair Forecasts (LH)Laboratory Corp. of America Holdings to Post Q4 2018 Earnings of $2.89 Per Share, William Blair Forecasts (LH)
www.americanbankingnews.com - May 1 at 7:04 AM
How LabCorp's sale of Covance Food Solutions will impact headcountsHow LabCorp's sale of Covance Food Solutions will impact headcounts
finance.yahoo.com - April 30 at 4:35 PM
Laboratory Corp. of America (LH) Downgraded by Zacks Investment ResearchLaboratory Corp. of America (LH) Downgraded by Zacks Investment Research
www.americanbankingnews.com - April 30 at 12:50 PM
LabCorp to sell Covance Food SolutionsLabCorp to sell Covance Food Solutions
finance.yahoo.com - April 30 at 9:26 AM
Laboratory Corp. of America Holdings (LH) Expected to Post Quarterly Sales of $2.87 BillionLaboratory Corp. of America Holdings (LH) Expected to Post Quarterly Sales of $2.87 Billion
www.americanbankingnews.com - April 30 at 4:50 AM
FY2018 EPS Estimates for Laboratory Corp. of America Holdings Raised by Gabelli (LH)FY2018 EPS Estimates for Laboratory Corp. of America Holdings Raised by Gabelli (LH)
www.americanbankingnews.com - April 30 at 3:42 AM
FY2018 Earnings Estimate for Laboratory Corp. of America Holdings Issued By Jefferies Group (LH)FY2018 Earnings Estimate for Laboratory Corp. of America Holdings Issued By Jefferies Group (LH)
www.americanbankingnews.com - April 30 at 3:42 AM
Laboratory Corp. of America Holdings (LH) Receives Average Recommendation of "Buy" from BrokeragesLaboratory Corp. of America Holdings (LH) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - April 30 at 3:34 AM
SunTrust Banks Brokers Reduce Earnings Estimates for Laboratory Corp. of America Holdings (LH)SunTrust Banks Brokers Reduce Earnings Estimates for Laboratory Corp. of America Holdings (LH)
www.americanbankingnews.com - April 30 at 1:52 AM
Research Analysts Set Expectations for Laboratory Corp. of America Holdings Q2 2018 Earnings (LH)Research Analysts Set Expectations for Laboratory Corp. of America Holdings' Q2 2018 Earnings (LH)
www.americanbankingnews.com - April 30 at 1:52 AM
Reviewing Elekta (EKTAY) & Laboratory Corp. of America (LH)Reviewing Elekta (EKTAY) & Laboratory Corp. of America (LH)
www.americanbankingnews.com - April 29 at 11:16 PM
 Analysts Anticipate Laboratory Corp. of America Holdings (LH) Will Announce Earnings of $2.95 Per Share Analysts Anticipate Laboratory Corp. of America Holdings (LH) Will Announce Earnings of $2.95 Per Share
www.americanbankingnews.com - April 28 at 5:14 AM
Equities Analysts Set Expectations for Laboratory Corp. of America Holdings Q1 2019 Earnings (LH)Equities Analysts Set Expectations for Laboratory Corp. of America Holdings' Q1 2019 Earnings (LH)
www.americanbankingnews.com - April 27 at 9:52 AM
Edited Transcript of LH earnings conference call or presentation 25-Apr-18 1:00pm GMTEdited Transcript of LH earnings conference call or presentation 25-Apr-18 1:00pm GMT
finance.yahoo.com - April 27 at 9:47 AM
Equities Analysts Issue Forecasts for Laboratory Corp. of America Holdings FY2018 Earnings (LH)Equities Analysts Issue Forecasts for Laboratory Corp. of America Holdings' FY2018 Earnings (LH)
www.americanbankingnews.com - April 27 at 9:25 AM
Q2 2018 EPS Estimates for Laboratory Corp. of America Holdings Decreased by Analyst (LH)Q2 2018 EPS Estimates for Laboratory Corp. of America Holdings Decreased by Analyst (LH)
www.americanbankingnews.com - April 27 at 7:52 AM
Form 8-K LABORATORY CORP OF AMERI For: Apr 24Form 8-K LABORATORY CORP OF AMERI For: Apr 24
www.streetinsider.com - April 26 at 4:36 PM
Laboratory Corp. of America (LH) Lifted to Buy at ValuEngineLaboratory Corp. of America (LH) Lifted to Buy at ValuEngine
www.americanbankingnews.com - April 26 at 2:04 PM
Laboratory Corp. of America Holdings (LH) CEO David P. King Sells 49,967 SharesLaboratory Corp. of America Holdings (LH) CEO David P. King Sells 49,967 Shares
www.americanbankingnews.com - April 25 at 7:10 PM
Laboratory of America Holdings (LH) Q1 2018 Results - Earnings Call TranscriptLaboratory of America Holdings (LH) Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - April 25 at 4:45 PM
Laboratory Corp. of America (LH) Issues Quarterly  Earnings ResultsLaboratory Corp. of America (LH) Issues Quarterly Earnings Results
www.americanbankingnews.com - April 25 at 11:23 AM
Laboratory Corp. of America (LH) Updates FY18 Earnings GuidanceLaboratory Corp. of America (LH) Updates FY18 Earnings Guidance
www.americanbankingnews.com - April 25 at 9:50 AM
Laboratory Corporation Of America Holdings Q1 adjusted earnings of $2.78 per shareLaboratory Corporation Of America Holdings Q1 adjusted earnings of $2.78 per share
www.nasdaq.com - April 25 at 9:20 AM
LabCorp: 1Q Earnings SnapshotLabCorp: 1Q Earnings Snapshot
finance.yahoo.com - April 25 at 9:20 AM
LabCorp quarterly profit falls 5.4 pctLabCorp quarterly profit falls 5.4 pct
finance.yahoo.com - April 25 at 9:20 AM
LabCorp quarterly profit beats estimatesLabCorp quarterly profit beats estimates
finance.yahoo.com - April 25 at 9:20 AM
LabCorp and Mount Sinai Health System Enhance Laboratory Operations to Improve Patient CareLabCorp and Mount Sinai Health System Enhance Laboratory Operations to Improve Patient Care
finance.yahoo.com - April 24 at 9:14 AM
Walgreens to add LabCorp patient centers in 10 Florida stores, including OrlandoWalgreens to add LabCorp patient centers in 10 Florida stores, including Orlando
finance.yahoo.com - April 23 at 4:34 PM
LabCorp at Walgreens Expands into FloridaLabCorp at Walgreens Expands into Florida
finance.yahoo.com - April 23 at 9:01 AM
Stock Traders Buy Large Volume of Laboratory Corp. of America Put Options (LH)Stock Traders Buy Large Volume of Laboratory Corp. of America Put Options (LH)
www.americanbankingnews.com - April 20 at 7:09 AM
Credit Suisse Group Lowers Laboratory Corp. of America (LH) to HoldCredit Suisse Group Lowers Laboratory Corp. of America (LH) to Hold
www.americanbankingnews.com - April 18 at 2:58 PM
Laboratory Corp. of America (LH) Set to Announce Quarterly Earnings on WednesdayLaboratory Corp. of America (LH) Set to Announce Quarterly Earnings on Wednesday
www.americanbankingnews.com - April 18 at 3:10 AM
Can LaunchPad Aid LabCorp's (LH) Covance Arm in Q1 Earnings?Can LaunchPad Aid LabCorp's (LH) Covance Arm in Q1 Earnings?
finance.yahoo.com - April 17 at 5:03 PM

SEC Filings

LabCorp (NYSE:LH) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

LabCorp (NYSE:LH) Income Statement, Balance Sheet and Cash Flow Statement

Chart

LabCorp (NYSE LH) Stock Chart for Friday, May, 25, 2018

Loading chart…

This page was last updated on 5/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.